Welcome to Ningbo Zhongyuan Biotechnology Co., Ltd./Welcome to Guizhou Zhongyuan Biotechnology Co., Ltd.

中

网站首页

Collaborate with tumor initiating cell research and treatment institutions in the United States and other countries

Collaborate with leading cancer initiating cell research and treatment facilities in the United States and other countries, including:
A. OntaGen Biotech Canada. OntaGen provides specific tumor early diagnosis, tumor immunotherapy and tumor personalized treatment technology worldwide. As a OntaGen Chinese partner, Zhongyuan has introduced technologies such as cryobiological freezing technology, specific tumor early diagnosis technology and tumor cell immunotherapy.
B. Comprehensive technical cooperation with the University of Michigan's Center for Surgery, Cancer Center and Translational Medicine, led by Fellow Simeone, related to gastrointestinal tumor tissue storage, tumor initiating cells, and individualized treatment.
C., in collaboration with Dr. Ginestier of the French National Institute of Health and Medical Research (ISERM), to conduct research and development of technologies related to breast cancer tumor-initiating cells.
D. Collaborate with Cell Pathways Biologics in the United States on the latest personalized therapy testing technology.

Other News

2023/10/24

How can you score your immunity? Scientists Introduce Assessment Criteria

According to a report on the website of the British "New Scientist" weekly on January 31, when you cover your quilt and wipe your nose because of the third cold this year, you may wonder if your immune system is working. This is the question we all want to know: Is our immune system healthy? Now, an emerging field of immunology tries to answer this question by "scoring" your immune system. The aim is to help people prepare for a rainy day, prompting them to change their lifestyle and avoid getting sick.

View Details

2023/10/24

Commonly used immune function assessment indicators

The immune system is the basic guarantee of human health, and 90% of diseases are related to immunity. However, how to quantitatively evaluate immunity and how to establish an immunity evaluation system is still an urgent problem to be solved.

View Details